Globus Medical (GMED) Earnings Analysis

Globus Medical (GMED) next reports earnings on 2026-08-06, consensus EPS 1.12 USD. Last quarter (2026-05-07) it beat with EPS 1.12 USD vs 0.92 USD est (+21.7%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 17.36.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does GMED next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate1.12 USD
Revenue estimate0.78B

GMED earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-071.12 USD0.92 USD+21.7%Beat
2025-11-061.18 USD0.781 USD+51.1%Beat
2025-08-070.86 USD0.76 USD+13.2%Beat
2025-02-200.84 USD0.74 USD+13.5%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

GMED valuation and analyst view

Trailing P/E17.36
Trailing EPS4.335 USD
Price / book2.16
Dividend yield0.00%
Market cap10.17B
Analyst consensusBuy (26 buy / 9 hold / 1 sell)
Avg price target101.29 USD

Related research pages

Frequently asked questions

When is Globus Medical (GMED)'s next earnings date?

Globus Medical is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 1.12 USD and revenue estimate of 0.78B.

Did GMED beat earnings last quarter?

In its 2026-05-07 report, GMED posted EPS of 1.12 USD versus a 0.92 USD estimate — a beat of 21.7%.

What is GMED's earnings track record?

Over the last 4 reported quarters with consensus data, GMED beat estimates 4 times (100%).

What is GMED's current P/E ratio and EPS?

GMED trades at a trailing P/E of 17.36 on trailing EPS of 4.334535031470701 USD.

What do analysts rate GMED?

Analyst consensus is "Buy" across 36 ratings (0 strong buy, 26 buy, 9 hold, 1 sell, 0 strong sell). Average 12-month price target: 101.29 USD.